CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Kyverna Therapeutics, Inc.

KYTX
$440MSmall Cap

Next catalyst

Phase 2April 2027

KYV-101

Systemic Sclerosis

Get an email about KYTX's next catalysts

Track Kyverna Therapeutics (KYTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 2 more upcoming events in our data (Phase 2 readout, Phase 3 readout).See the timeline

Catalyst Timeline

3 upcoming, 2 past

Phase 2Next

KYV-101 Phase 2 Est. Readout

April 2027~KYV-101120

Primary completion for KYV-101 trial (NCT06384976) in Multiple Sclerosis, Primary Progressive

Source
Phase 2

KYV101 Phase 2 Est. Readout (COMPARE)

June 2027~KYV10113

Estimated primary completion for KYV101 trial (NCT06475495) in Rheumatoid Arthritis. Topline data typically follows completion by weeks to months.

Source
Phase 3

KYV-101 Phase 3 Est. Readout

September 2027~KYV-10166

Primary completion for KYV-101 trial (NCT06193889) in Myasthenia Gravis

Source

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaEMERYVILLE129 employees
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Kyverna Therapeutics, Inc.'s drug pipeline?→

CatalystAlert tracks 5 drug candidates in Kyverna Therapeutics, Inc.'s (KYTX) pipeline across Phase 3, Phase 2. Its lead program is KYV-101 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Kyverna Therapeutics, Inc.'s next FDA catalyst?→

Kyverna Therapeutics, Inc.'s (KYTX) next tracked catalyst is a Phase 2 readout expected April 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track KYTX biotech catalysts?→

Add KYTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Kyverna Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply